A. Muhammad

Leptin signalling, obesity and prostate cancer: molecular and clinical perspective on the old dilemma

H. Alshaker, M. Winkler, K. Sacco, 2015, Oncotarget.

Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer

H. Alshaker, L. Monzon, K. Sacco, 2015, Journal of Cancer Research and Clinical Oncology.

Membranous Glomerulonephritis as an Uncommon Presentation of Secondary Syphilis: A Reminder on Therapeutic Decision-Making in Clinical Practice

Faisal Inayat, Talal Almas, M. Sharshir, 2020, Journal of investigative medicine high impact case reports.

Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experience

N. Vasdev, J. Bridgewater, D. Hochhauser, 2020, medRxiv.

Leptomeningeal carcinomatosis as the primary presentation of relapse in breast cancer.

H. Alshaker, M. Islam, L. Monzon, 2016, Oncology letters.

A PHASE II STUDY OF CISPLATIN AND 5-FLUOROURACIL COMBINATION CHEMOTHERAPY AND CONCURRENT THORACIC RADIATION IN SQUAMOUS CELL CARCINOMA OF LUNG

Shahid Rasul, N. Haider, A. Muhammad, 2007 .